Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis
Clinical trial NCT04895917 · TERMINATED
Trial details
- NCT number
- NCT04895917
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2024-12-18
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.